Anzeige
Mehr »
Dienstag, 26.08.2025 - Börsentäglich über 12.000 News
Breaking: AlsetAI zündet nächste Stufe - Neue Allianz mit CHIP Datacentres & Hochkarätige Vorstände markieren Wendepunkt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40J1L | ISIN: CA22112H1010 | Ticker-Symbol: ET8
Frankfurt
26.08.25 | 14:26
2,700 Euro
+2,27 % +0,060
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
COSCIENS BIOPHARMA INC Chart 1 Jahr
5-Tage-Chart
COSCIENS BIOPHARMA INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,4002,80021:36
2,4002,58015.08.

Aktuelle News zur COSCIENS BIOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
16:40COSCIENS Biopharma Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities5
COSCIENS BIOPHARMA Aktie jetzt für 0€ handeln
15.08.COSCIENS Biopharma GAAP EPS of -$0.75, revenue of $2.7M7
14.08.COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update143COSCIENS Board of Directors approves a plan to voluntarily delist from Nasdaq, while retaining the Company's listing on the TSX TORONTO, ONTARIO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma...
► Artikel lesen
14.08.COSCIENS Biopharma Inc. - 6-K, Report of foreign issuer2
01.07.Cosciens Biopharma Inc: Cosciens shareholders approve all matters at AGSM4
01.07.COSCIENS Biopharma Inc.: COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders226TORONTO, ONTARIO, June 30, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) ("COSCIENS" or the "Company"), a life sciences company developing and commercializing a diversified...
► Artikel lesen
30.06.COSCIENS Biopharma Inc. - 6-K, Report of foreign issuer1
09.06.COSCIENS Biopharma veröffentlicht zukunftsgerichtete Aussagen3
09.06.COSCIENS Biopharma Inc. - 6-K, Report of foreign issuer1
30.05.COSCIENS Biopharma reconstitutes board1
30.05.COSCIENS Biopharma Inc. - 6-K, Report of foreign issuer2
30.05.COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders324Reconstituted Board to Revitalize COSCIENS TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) today announced that it has entered into a resolution agreement...
► Artikel lesen
26.05.Cosciens Biopharma Inc: Cosciens Biopharma dissident nominates six directors4
26.05.COSCIENS Biopharma To Review Director Nominations From Goodwood3
26.05.COSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for the Upcoming Annual and Special Meeting of Shareholders1
23.05.Cosciens Biopharma Inc: Cosciens dissident Goodwood to nominate six directors7
23.05.Goodwood to Nominate New Directors for COSCIENS Biopharma Inc.1
20.05.COSCIENS Biopharma Inc. - 6-K, Report of foreign issuer4
13.05.COSCIENS Biopharma GAAP EPS of -$1.16, revenue of $1.5M4
13.05.COSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update166Repositioned as a pure-play natural-based product company following strategic review and pipeline prioritization Efforts continue to gain efficiencies through streamlining and cost cutting measures...
► Artikel lesen
Weiter >>
43 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
2,1,7